Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer | Zendy

Romain-David Seban | Zendy; Roman Rouzier | Zendy; Aurélien Latouche | Zendy; Nicolas Deleval | Zendy; JeanMarc Guinebretière | Zendy; Irène Buvat | Zendy; FrançoisClément Bidard | Zendy; Laurence Champion | Zendy

Open Access

Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer

Author(s) -

Romain-David Seban,

Roman Rouzier,

Aurélien Latouche,

Nicolas Deleval,

JeanMarc Guinebretière,

Irène Buvat,

FrançoisClément Bidard,

Laurence Champion

Publication year - 2021

Publication title -

european journal of nuclear medicine and molecular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.313

H-Index - 163

eISSN - 1619-7089

pISSN - 1619-7070

DOI - 10.1007/s00259-021-05322-2

Subject(s) - medicine , breast cancer , proportional hazards model , positron emission tomography , pet ct , logistic regression , retrospective cohort study , oncology , cancer , nuclear medicine

We evaluated whether biomarkers on baseline [ 18 F]-FDG PET/CT are associated with recurrence after surgery in patients with invasive breast cancer of no special type (NST).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research